Global Gastrointestinal Stromal Tumor Drug Supply, Demand and Key Producers, 2024-2030

Page: 166

Published Date: 29 Jul 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Gastrointestinal Stromal Tumor Drug market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Gastrointestinal Stromal Tumor Drug production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Gastrointestinal Stromal Tumor Drug and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gastrointestinal Stromal Tumor Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Gastrointestinal Stromal Tumor Drug total production and demand, 2019-2030, (K Units)
Global Gastrointestinal Stromal Tumor Drug total production value, 2019-2030, (USD Million)
Global Gastrointestinal Stromal Tumor Drug production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Gastrointestinal Stromal Tumor Drug consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Gastrointestinal Stromal Tumor Drug domestic production, consumption, key domestic manufacturers and share
Global Gastrointestinal Stromal Tumor Drug production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Gastrointestinal Stromal Tumor Drug production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Gastrointestinal Stromal Tumor Drug production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Gastrointestinal Stromal Tumor Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Bayer Pharmaceuticals, Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals, Actavis Generics, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., Apotex Inc., Mylan Pharms Inc., Bulat Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gastrointestinal Stromal Tumor Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Gastrointestinal Stromal Tumor Drug Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Gastrointestinal Stromal Tumor Drug Market, Segmentation by Type:
Imatinib
Sunitinib
Regorafenib
Ripretinib
Others

Global Gastrointestinal Stromal Tumor Drug Market, Segmentation by Application:
Hospital
Clinic
Others

Companies Profiled:
Novartis
Bayer Pharmaceuticals
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Apotex Inc.
Mylan Pharms Inc.
Bulat Pharmaceutical
MSN Laboratories
Vannsh Life Sciences
Beacon Pharmaceuticals
Drug International
Deciphera Pharmaceuticals
CSPC Pharmaceuticals
Hansoh Pharmaceuticals
Kelun Pharmaceuticals
Zai Lab
CStone Pharmaceuticals
China Biopharmaceuticals

Key Questions Answered:
1. How big is the global Gastrointestinal Stromal Tumor Drug market?
2. What is the demand of the global Gastrointestinal Stromal Tumor Drug market?
3. What is the year over year growth of the global Gastrointestinal Stromal Tumor Drug market?
4. What is the production and production value of the global Gastrointestinal Stromal Tumor Drug market?
5. Who are the key producers in the global Gastrointestinal Stromal Tumor Drug market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Gastrointestinal Stromal Tumor Drug Introduction
    1.2 World Gastrointestinal Stromal Tumor Drug Supply & Forecast
        1.2.1 World Gastrointestinal Stromal Tumor Drug Production Value (2019 & 2023 & 2030)
        1.2.2 World Gastrointestinal Stromal Tumor Drug Production (2019-2030)
        1.2.3 World Gastrointestinal Stromal Tumor Drug Pricing Trends (2019-2030)
    1.3 World Gastrointestinal Stromal Tumor Drug Production by Region (Based on Production Site)
        1.3.1 World Gastrointestinal Stromal Tumor Drug Production Value by Region (2019-2030)
        1.3.2 World Gastrointestinal Stromal Tumor Drug Production by Region (2019-2030)
        1.3.3 World Gastrointestinal Stromal Tumor Drug Average Price by Region (2019-2030)
        1.3.4 North America Gastrointestinal Stromal Tumor Drug Production (2019-2030)
        1.3.5 Europe Gastrointestinal Stromal Tumor Drug Production (2019-2030)
        1.3.6 China Gastrointestinal Stromal Tumor Drug Production (2019-2030)
        1.3.7 Japan Gastrointestinal Stromal Tumor Drug Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Gastrointestinal Stromal Tumor Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Gastrointestinal Stromal Tumor Drug Major Market Trends

2 Demand Summary
    2.1 World Gastrointestinal Stromal Tumor Drug Demand (2019-2030)
    2.2 World Gastrointestinal Stromal Tumor Drug Consumption by Region
        2.2.1 World Gastrointestinal Stromal Tumor Drug Consumption by Region (2019-2024)
        2.2.2 World Gastrointestinal Stromal Tumor Drug Consumption Forecast by Region (2025-2030)
    2.3 United States Gastrointestinal Stromal Tumor Drug Consumption (2019-2030)
    2.4 China Gastrointestinal Stromal Tumor Drug Consumption (2019-2030)
    2.5 Europe Gastrointestinal Stromal Tumor Drug Consumption (2019-2030)
    2.6 Japan Gastrointestinal Stromal Tumor Drug Consumption (2019-2030)
    2.7 South Korea Gastrointestinal Stromal Tumor Drug Consumption (2019-2030)
    2.8 ASEAN Gastrointestinal Stromal Tumor Drug Consumption (2019-2030)
    2.9 India Gastrointestinal Stromal Tumor Drug Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Gastrointestinal Stromal Tumor Drug Production Value by Manufacturer (2019-2024)
    3.2 World Gastrointestinal Stromal Tumor Drug Production by Manufacturer (2019-2024)
    3.3 World Gastrointestinal Stromal Tumor Drug Average Price by Manufacturer (2019-2024)
    3.4 Gastrointestinal Stromal Tumor Drug Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Gastrointestinal Stromal Tumor Drug Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Gastrointestinal Stromal Tumor Drug in 2023
        3.5.3 Global Concentration Ratios (CR8) for Gastrointestinal Stromal Tumor Drug in 2023
    3.6 Gastrointestinal Stromal Tumor Drug Market: Overall Company Footprint Analysis
        3.6.1 Gastrointestinal Stromal Tumor Drug Market: Region Footprint
        3.6.2 Gastrointestinal Stromal Tumor Drug Market: Company Product Type Footprint
        3.6.3 Gastrointestinal Stromal Tumor Drug Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Gastrointestinal Stromal Tumor Drug Production Value Comparison
        4.1.1 United States VS China: Gastrointestinal Stromal Tumor Drug Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Gastrointestinal Stromal Tumor Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Gastrointestinal Stromal Tumor Drug Production Comparison
        4.2.1 United States VS China: Gastrointestinal Stromal Tumor Drug Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Gastrointestinal Stromal Tumor Drug Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Gastrointestinal Stromal Tumor Drug Consumption Comparison
        4.3.1 United States VS China: Gastrointestinal Stromal Tumor Drug Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Gastrointestinal Stromal Tumor Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Gastrointestinal Stromal Tumor Drug Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Gastrointestinal Stromal Tumor Drug Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Gastrointestinal Stromal Tumor Drug Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Gastrointestinal Stromal Tumor Drug Production (2019-2024)
    4.5 China Based Gastrointestinal Stromal Tumor Drug Manufacturers and Market Share
        4.5.1 China Based Gastrointestinal Stromal Tumor Drug Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Gastrointestinal Stromal Tumor Drug Production Value (2019-2024)
        4.5.3 China Based Manufacturers Gastrointestinal Stromal Tumor Drug Production (2019-2024)
    4.6 Rest of World Based Gastrointestinal Stromal Tumor Drug Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Gastrointestinal Stromal Tumor Drug Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Gastrointestinal Stromal Tumor Drug Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Gastrointestinal Stromal Tumor Drug Production (2019-2024)

5 Market Analysis by Type
    5.1 World Gastrointestinal Stromal Tumor Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Imatinib
        5.2.2 Sunitinib
        5.2.3 Regorafenib
        5.2.4 Ripretinib
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Gastrointestinal Stromal Tumor Drug Production by Type (2019-2030)
        5.3.2 World Gastrointestinal Stromal Tumor Drug Production Value by Type (2019-2030)
        5.3.3 World Gastrointestinal Stromal Tumor Drug Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Gastrointestinal Stromal Tumor Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Gastrointestinal Stromal Tumor Drug Production by Application (2019-2030)
        6.3.2 World Gastrointestinal Stromal Tumor Drug Production Value by Application (2019-2030)
        6.3.3 World Gastrointestinal Stromal Tumor Drug Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Details
        7.1.2 Novartis Major Business
        7.1.3 Novartis Gastrointestinal Stromal Tumor Drug Product and Services
        7.1.4 Novartis Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Novartis Recent Developments/Updates
        7.1.6 Novartis Competitive Strengths & Weaknesses
    7.2 Bayer Pharmaceuticals
        7.2.1 Bayer Pharmaceuticals Details
        7.2.2 Bayer Pharmaceuticals Major Business
        7.2.3 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        7.2.4 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Bayer Pharmaceuticals Recent Developments/Updates
        7.2.6 Bayer Pharmaceuticals Competitive Strengths & Weaknesses
    7.3 Glenmark Pharmaceuticals Ltd.
        7.3.1 Glenmark Pharmaceuticals Ltd. Details
        7.3.2 Glenmark Pharmaceuticals Ltd. Major Business
        7.3.3 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Product and Services
        7.3.4 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Glenmark Pharmaceuticals Ltd. Recent Developments/Updates
        7.3.6 Glenmark Pharmaceuticals Ltd. Competitive Strengths & Weaknesses
    7.4 Sun Pharmaceuticals
        7.4.1 Sun Pharmaceuticals Details
        7.4.2 Sun Pharmaceuticals Major Business
        7.4.3 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        7.4.4 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Sun Pharmaceuticals Recent Developments/Updates
        7.4.6 Sun Pharmaceuticals Competitive Strengths & Weaknesses
    7.5 Actavis Generics
        7.5.1 Actavis Generics Details
        7.5.2 Actavis Generics Major Business
        7.5.3 Actavis Generics Gastrointestinal Stromal Tumor Drug Product and Services
        7.5.4 Actavis Generics Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Actavis Generics Recent Developments/Updates
        7.5.6 Actavis Generics Competitive Strengths & Weaknesses
    7.6 Dr. Reddy's Laboratories
        7.6.1 Dr. Reddy's Laboratories Details
        7.6.2 Dr. Reddy's Laboratories Major Business
        7.6.3 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Product and Services
        7.6.4 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Dr. Reddy's Laboratories Recent Developments/Updates
        7.6.6 Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
    7.7 Teva Pharmaceutical Industries Ltd.
        7.7.1 Teva Pharmaceutical Industries Ltd. Details
        7.7.2 Teva Pharmaceutical Industries Ltd. Major Business
        7.7.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Product and Services
        7.7.4 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
        7.7.6 Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
    7.8 Apotex Inc.
        7.8.1 Apotex Inc. Details
        7.8.2 Apotex Inc. Major Business
        7.8.3 Apotex Inc. Gastrointestinal Stromal Tumor Drug Product and Services
        7.8.4 Apotex Inc. Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Apotex Inc. Recent Developments/Updates
        7.8.6 Apotex Inc. Competitive Strengths & Weaknesses
    7.9 Mylan Pharms Inc.
        7.9.1 Mylan Pharms Inc. Details
        7.9.2 Mylan Pharms Inc. Major Business
        7.9.3 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Product and Services
        7.9.4 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Mylan Pharms Inc. Recent Developments/Updates
        7.9.6 Mylan Pharms Inc. Competitive Strengths & Weaknesses
    7.10 Bulat Pharmaceutical
        7.10.1 Bulat Pharmaceutical Details
        7.10.2 Bulat Pharmaceutical Major Business
        7.10.3 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Product and Services
        7.10.4 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Bulat Pharmaceutical Recent Developments/Updates
        7.10.6 Bulat Pharmaceutical Competitive Strengths & Weaknesses
    7.11 MSN Laboratories
        7.11.1 MSN Laboratories Details
        7.11.2 MSN Laboratories Major Business
        7.11.3 MSN Laboratories Gastrointestinal Stromal Tumor Drug Product and Services
        7.11.4 MSN Laboratories Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 MSN Laboratories Recent Developments/Updates
        7.11.6 MSN Laboratories Competitive Strengths & Weaknesses
    7.12 Vannsh Life Sciences
        7.12.1 Vannsh Life Sciences Details
        7.12.2 Vannsh Life Sciences Major Business
        7.12.3 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Product and Services
        7.12.4 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Vannsh Life Sciences Recent Developments/Updates
        7.12.6 Vannsh Life Sciences Competitive Strengths & Weaknesses
    7.13 Beacon Pharmaceuticals
        7.13.1 Beacon Pharmaceuticals Details
        7.13.2 Beacon Pharmaceuticals Major Business
        7.13.3 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        7.13.4 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Beacon Pharmaceuticals Recent Developments/Updates
        7.13.6 Beacon Pharmaceuticals Competitive Strengths & Weaknesses
    7.14 Drug International
        7.14.1 Drug International Details
        7.14.2 Drug International Major Business
        7.14.3 Drug International Gastrointestinal Stromal Tumor Drug Product and Services
        7.14.4 Drug International Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.14.5 Drug International Recent Developments/Updates
        7.14.6 Drug International Competitive Strengths & Weaknesses
    7.15 Deciphera Pharmaceuticals
        7.15.1 Deciphera Pharmaceuticals Details
        7.15.2 Deciphera Pharmaceuticals Major Business
        7.15.3 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        7.15.4 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.15.5 Deciphera Pharmaceuticals Recent Developments/Updates
        7.15.6 Deciphera Pharmaceuticals Competitive Strengths & Weaknesses
    7.16 CSPC Pharmaceuticals
        7.16.1 CSPC Pharmaceuticals Details
        7.16.2 CSPC Pharmaceuticals Major Business
        7.16.3 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        7.16.4 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.16.5 CSPC Pharmaceuticals Recent Developments/Updates
        7.16.6 CSPC Pharmaceuticals Competitive Strengths & Weaknesses
    7.17 Hansoh Pharmaceuticals
        7.17.1 Hansoh Pharmaceuticals Details
        7.17.2 Hansoh Pharmaceuticals Major Business
        7.17.3 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        7.17.4 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.17.5 Hansoh Pharmaceuticals Recent Developments/Updates
        7.17.6 Hansoh Pharmaceuticals Competitive Strengths & Weaknesses
    7.18 Kelun Pharmaceuticals
        7.18.1 Kelun Pharmaceuticals Details
        7.18.2 Kelun Pharmaceuticals Major Business
        7.18.3 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        7.18.4 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.18.5 Kelun Pharmaceuticals Recent Developments/Updates
        7.18.6 Kelun Pharmaceuticals Competitive Strengths & Weaknesses
    7.19 Zai Lab
        7.19.1 Zai Lab Details
        7.19.2 Zai Lab Major Business
        7.19.3 Zai Lab Gastrointestinal Stromal Tumor Drug Product and Services
        7.19.4 Zai Lab Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.19.5 Zai Lab Recent Developments/Updates
        7.19.6 Zai Lab Competitive Strengths & Weaknesses
    7.20 CStone Pharmaceuticals
        7.20.1 CStone Pharmaceuticals Details
        7.20.2 CStone Pharmaceuticals Major Business
        7.20.3 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        7.20.4 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.20.5 CStone Pharmaceuticals Recent Developments/Updates
        7.20.6 CStone Pharmaceuticals Competitive Strengths & Weaknesses
    7.21 China Biopharmaceuticals
        7.21.1 China Biopharmaceuticals Details
        7.21.2 China Biopharmaceuticals Major Business
        7.21.3 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        7.21.4 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.21.5 China Biopharmaceuticals Recent Developments/Updates
        7.21.6 China Biopharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Gastrointestinal Stromal Tumor Drug Industry Chain
    8.2 Gastrointestinal Stromal Tumor Drug Upstream Analysis
        8.2.1 Gastrointestinal Stromal Tumor Drug Core Raw Materials
        8.2.2 Main Manufacturers of Gastrointestinal Stromal Tumor Drug Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Gastrointestinal Stromal Tumor Drug Production Mode
    8.6 Gastrointestinal Stromal Tumor Drug Procurement Model
    8.7 Gastrointestinal Stromal Tumor Drug Industry Sales Model and Sales Channels
        8.7.1 Gastrointestinal Stromal Tumor Drug Sales Model
        8.7.2 Gastrointestinal Stromal Tumor Drug Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Gastrointestinal Stromal Tumor Drug Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Gastrointestinal Stromal Tumor Drug Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Gastrointestinal Stromal Tumor Drug Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Gastrointestinal Stromal Tumor Drug Production Value Market Share by Region (2019-2024)
 Table 5. World Gastrointestinal Stromal Tumor Drug Production Value Market Share by Region (2025-2030)
 Table 6. World Gastrointestinal Stromal Tumor Drug Production by Region (2019-2024) & (K Units)
 Table 7. World Gastrointestinal Stromal Tumor Drug Production by Region (2025-2030) & (K Units)
 Table 8. World Gastrointestinal Stromal Tumor Drug Production Market Share by Region (2019-2024)
 Table 9. World Gastrointestinal Stromal Tumor Drug Production Market Share by Region (2025-2030)
 Table 10. World Gastrointestinal Stromal Tumor Drug Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World Gastrointestinal Stromal Tumor Drug Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. Gastrointestinal Stromal Tumor Drug Major Market Trends
 Table 13. World Gastrointestinal Stromal Tumor Drug Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World Gastrointestinal Stromal Tumor Drug Consumption by Region (2019-2024) & (K Units)
 Table 15. World Gastrointestinal Stromal Tumor Drug Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World Gastrointestinal Stromal Tumor Drug Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Gastrointestinal Stromal Tumor Drug Producers in 2023
 Table 18. World Gastrointestinal Stromal Tumor Drug Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key Gastrointestinal Stromal Tumor Drug Producers in 2023
 Table 20. World Gastrointestinal Stromal Tumor Drug Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global Gastrointestinal Stromal Tumor Drug Company Evaluation Quadrant
 Table 22. World Gastrointestinal Stromal Tumor Drug Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Gastrointestinal Stromal Tumor Drug Production Site of Key Manufacturer
 Table 24. Gastrointestinal Stromal Tumor Drug Market: Company Product Type Footprint
 Table 25. Gastrointestinal Stromal Tumor Drug Market: Company Product Application Footprint
 Table 26. Gastrointestinal Stromal Tumor Drug Competitive Factors
 Table 27. Gastrointestinal Stromal Tumor Drug New Entrant and Capacity Expansion Plans
 Table 28. Gastrointestinal Stromal Tumor Drug Mergers & Acquisitions Activity
 Table 29. United States VS China Gastrointestinal Stromal Tumor Drug Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Gastrointestinal Stromal Tumor Drug Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China Gastrointestinal Stromal Tumor Drug Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based Gastrointestinal Stromal Tumor Drug Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Gastrointestinal Stromal Tumor Drug Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Gastrointestinal Stromal Tumor Drug Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Gastrointestinal Stromal Tumor Drug Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers Gastrointestinal Stromal Tumor Drug Production Market Share (2019-2024)
 Table 37. China Based Gastrointestinal Stromal Tumor Drug Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Gastrointestinal Stromal Tumor Drug Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Gastrointestinal Stromal Tumor Drug Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Gastrointestinal Stromal Tumor Drug Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers Gastrointestinal Stromal Tumor Drug Production Market Share (2019-2024)
 Table 42. Rest of World Based Gastrointestinal Stromal Tumor Drug Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Gastrointestinal Stromal Tumor Drug Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Gastrointestinal Stromal Tumor Drug Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Gastrointestinal Stromal Tumor Drug Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers Gastrointestinal Stromal Tumor Drug Production Market Share (2019-2024)
 Table 47. World Gastrointestinal Stromal Tumor Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Gastrointestinal Stromal Tumor Drug Production by Type (2019-2024) & (K Units)
 Table 49. World Gastrointestinal Stromal Tumor Drug Production by Type (2025-2030) & (K Units)
 Table 50. World Gastrointestinal Stromal Tumor Drug Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Gastrointestinal Stromal Tumor Drug Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Gastrointestinal Stromal Tumor Drug Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World Gastrointestinal Stromal Tumor Drug Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World Gastrointestinal Stromal Tumor Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Gastrointestinal Stromal Tumor Drug Production by Application (2019-2024) & (K Units)
 Table 56. World Gastrointestinal Stromal Tumor Drug Production by Application (2025-2030) & (K Units)
 Table 57. World Gastrointestinal Stromal Tumor Drug Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Gastrointestinal Stromal Tumor Drug Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Gastrointestinal Stromal Tumor Drug Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World Gastrointestinal Stromal Tumor Drug Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. Novartis Basic Information, Manufacturing Base and Competitors
 Table 62. Novartis Major Business
 Table 63. Novartis Gastrointestinal Stromal Tumor Drug Product and Services
 Table 64. Novartis Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Novartis Recent Developments/Updates
 Table 66. Novartis Competitive Strengths & Weaknesses
 Table 67. Bayer Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 68. Bayer Pharmaceuticals Major Business
 Table 69. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 70. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Bayer Pharmaceuticals Recent Developments/Updates
 Table 72. Bayer Pharmaceuticals Competitive Strengths & Weaknesses
 Table 73. Glenmark Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
 Table 74. Glenmark Pharmaceuticals Ltd. Major Business
 Table 75. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Product and Services
 Table 76. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Glenmark Pharmaceuticals Ltd. Recent Developments/Updates
 Table 78. Glenmark Pharmaceuticals Ltd. Competitive Strengths & Weaknesses
 Table 79. Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 80. Sun Pharmaceuticals Major Business
 Table 81. Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 82. Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Sun Pharmaceuticals Recent Developments/Updates
 Table 84. Sun Pharmaceuticals Competitive Strengths & Weaknesses
 Table 85. Actavis Generics Basic Information, Manufacturing Base and Competitors
 Table 86. Actavis Generics Major Business
 Table 87. Actavis Generics Gastrointestinal Stromal Tumor Drug Product and Services
 Table 88. Actavis Generics Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Actavis Generics Recent Developments/Updates
 Table 90. Actavis Generics Competitive Strengths & Weaknesses
 Table 91. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
 Table 92. Dr. Reddy's Laboratories Major Business
 Table 93. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Product and Services
 Table 94. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 96. Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
 Table 97. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
 Table 98. Teva Pharmaceutical Industries Ltd. Major Business
 Table 99. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Product and Services
 Table 100. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
 Table 102. Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
 Table 103. Apotex Inc. Basic Information, Manufacturing Base and Competitors
 Table 104. Apotex Inc. Major Business
 Table 105. Apotex Inc. Gastrointestinal Stromal Tumor Drug Product and Services
 Table 106. Apotex Inc. Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. Apotex Inc. Recent Developments/Updates
 Table 108. Apotex Inc. Competitive Strengths & Weaknesses
 Table 109. Mylan Pharms Inc. Basic Information, Manufacturing Base and Competitors
 Table 110. Mylan Pharms Inc. Major Business
 Table 111. Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Product and Services
 Table 112. Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Mylan Pharms Inc. Recent Developments/Updates
 Table 114. Mylan Pharms Inc. Competitive Strengths & Weaknesses
 Table 115. Bulat Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 116. Bulat Pharmaceutical Major Business
 Table 117. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Product and Services
 Table 118. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 119. Bulat Pharmaceutical Recent Developments/Updates
 Table 120. Bulat Pharmaceutical Competitive Strengths & Weaknesses
 Table 121. MSN Laboratories Basic Information, Manufacturing Base and Competitors
 Table 122. MSN Laboratories Major Business
 Table 123. MSN Laboratories Gastrointestinal Stromal Tumor Drug Product and Services
 Table 124. MSN Laboratories Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 125. MSN Laboratories Recent Developments/Updates
 Table 126. MSN Laboratories Competitive Strengths & Weaknesses
 Table 127. Vannsh Life Sciences Basic Information, Manufacturing Base and Competitors
 Table 128. Vannsh Life Sciences Major Business
 Table 129. Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Product and Services
 Table 130. Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 131. Vannsh Life Sciences Recent Developments/Updates
 Table 132. Vannsh Life Sciences Competitive Strengths & Weaknesses
 Table 133. Beacon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 134. Beacon Pharmaceuticals Major Business
 Table 135. Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 136. Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 137. Beacon Pharmaceuticals Recent Developments/Updates
 Table 138. Beacon Pharmaceuticals Competitive Strengths & Weaknesses
 Table 139. Drug International Basic Information, Manufacturing Base and Competitors
 Table 140. Drug International Major Business
 Table 141. Drug International Gastrointestinal Stromal Tumor Drug Product and Services
 Table 142. Drug International Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 143. Drug International Recent Developments/Updates
 Table 144. Drug International Competitive Strengths & Weaknesses
 Table 145. Deciphera Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 146. Deciphera Pharmaceuticals Major Business
 Table 147. Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 148. Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 149. Deciphera Pharmaceuticals Recent Developments/Updates
 Table 150. Deciphera Pharmaceuticals Competitive Strengths & Weaknesses
 Table 151. CSPC Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 152. CSPC Pharmaceuticals Major Business
 Table 153. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 154. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 155. CSPC Pharmaceuticals Recent Developments/Updates
 Table 156. CSPC Pharmaceuticals Competitive Strengths & Weaknesses
 Table 157. Hansoh Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 158. Hansoh Pharmaceuticals Major Business
 Table 159. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 160. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 161. Hansoh Pharmaceuticals Recent Developments/Updates
 Table 162. Hansoh Pharmaceuticals Competitive Strengths & Weaknesses
 Table 163. Kelun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 164. Kelun Pharmaceuticals Major Business
 Table 165. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 166. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 167. Kelun Pharmaceuticals Recent Developments/Updates
 Table 168. Kelun Pharmaceuticals Competitive Strengths & Weaknesses
 Table 169. Zai Lab Basic Information, Manufacturing Base and Competitors
 Table 170. Zai Lab Major Business
 Table 171. Zai Lab Gastrointestinal Stromal Tumor Drug Product and Services
 Table 172. Zai Lab Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 173. Zai Lab Recent Developments/Updates
 Table 174. Zai Lab Competitive Strengths & Weaknesses
 Table 175. CStone Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 176. CStone Pharmaceuticals Major Business
 Table 177. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 178. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 179. CStone Pharmaceuticals Recent Developments/Updates
 Table 180. CStone Pharmaceuticals Competitive Strengths & Weaknesses
 Table 181. China Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 182. China Biopharmaceuticals Major Business
 Table 183. China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 184. China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 185. China Biopharmaceuticals Recent Developments/Updates
 Table 186. China Biopharmaceuticals Competitive Strengths & Weaknesses
 Table 187. Global Key Players of Gastrointestinal Stromal Tumor Drug Upstream (Raw Materials)
 Table 188. Global Gastrointestinal Stromal Tumor Drug Typical Customers
 Table 189. Gastrointestinal Stromal Tumor Drug Typical Distributors


List of Figures
 Figure 1. Gastrointestinal Stromal Tumor Drug Picture
 Figure 2. World Gastrointestinal Stromal Tumor Drug Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Gastrointestinal Stromal Tumor Drug Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Gastrointestinal Stromal Tumor Drug Production (2019-2030) & (K Units)
 Figure 5. World Gastrointestinal Stromal Tumor Drug Average Price (2019-2030) & (US$/Unit)
 Figure 6. World Gastrointestinal Stromal Tumor Drug Production Value Market Share by Region (2019-2030)
 Figure 7. World Gastrointestinal Stromal Tumor Drug Production Market Share by Region (2019-2030)
 Figure 8. North America Gastrointestinal Stromal Tumor Drug Production (2019-2030) & (K Units)
 Figure 9. Europe Gastrointestinal Stromal Tumor Drug Production (2019-2030) & (K Units)
 Figure 10. China Gastrointestinal Stromal Tumor Drug Production (2019-2030) & (K Units)
 Figure 11. Japan Gastrointestinal Stromal Tumor Drug Production (2019-2030) & (K Units)
 Figure 12. Gastrointestinal Stromal Tumor Drug Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Gastrointestinal Stromal Tumor Drug Consumption (2019-2030) & (K Units)
 Figure 15. World Gastrointestinal Stromal Tumor Drug Consumption Market Share by Region (2019-2030)
 Figure 16. United States Gastrointestinal Stromal Tumor Drug Consumption (2019-2030) & (K Units)
 Figure 17. China Gastrointestinal Stromal Tumor Drug Consumption (2019-2030) & (K Units)
 Figure 18. Europe Gastrointestinal Stromal Tumor Drug Consumption (2019-2030) & (K Units)
 Figure 19. Japan Gastrointestinal Stromal Tumor Drug Consumption (2019-2030) & (K Units)
 Figure 20. South Korea Gastrointestinal Stromal Tumor Drug Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN Gastrointestinal Stromal Tumor Drug Consumption (2019-2030) & (K Units)
 Figure 22. India Gastrointestinal Stromal Tumor Drug Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of Gastrointestinal Stromal Tumor Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Gastrointestinal Stromal Tumor Drug Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Gastrointestinal Stromal Tumor Drug Markets in 2023
 Figure 26. United States VS China: Gastrointestinal Stromal Tumor Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Gastrointestinal Stromal Tumor Drug Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Gastrointestinal Stromal Tumor Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Gastrointestinal Stromal Tumor Drug Production Market Share 2023
 Figure 30. China Based Manufacturers Gastrointestinal Stromal Tumor Drug Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Gastrointestinal Stromal Tumor Drug Production Market Share 2023
 Figure 32. World Gastrointestinal Stromal Tumor Drug Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Gastrointestinal Stromal Tumor Drug Production Value Market Share by Type in 2023
 Figure 34. Imatinib
 Figure 35. Sunitinib
 Figure 36. Regorafenib
 Figure 37. Ripretinib
 Figure 38. Others
 Figure 39. World Gastrointestinal Stromal Tumor Drug Production Market Share by Type (2019-2030)
 Figure 40. World Gastrointestinal Stromal Tumor Drug Production Value Market Share by Type (2019-2030)
 Figure 41. World Gastrointestinal Stromal Tumor Drug Average Price by Type (2019-2030) & (US$/Unit)
 Figure 42. World Gastrointestinal Stromal Tumor Drug Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 43. World Gastrointestinal Stromal Tumor Drug Production Value Market Share by Application in 2023
 Figure 44. Hospital
 Figure 45. Clinic
 Figure 46. Others
 Figure 47. World Gastrointestinal Stromal Tumor Drug Production Market Share by Application (2019-2030)
 Figure 48. World Gastrointestinal Stromal Tumor Drug Production Value Market Share by Application (2019-2030)
 Figure 49. World Gastrointestinal Stromal Tumor Drug Average Price by Application (2019-2030) & (US$/Unit)
 Figure 50. Gastrointestinal Stromal Tumor Drug Industry Chain
 Figure 51. Gastrointestinal Stromal Tumor Drug Procurement Model
 Figure 52. Gastrointestinal Stromal Tumor Drug Sales Model
 Figure 53. Gastrointestinal Stromal Tumor Drug Sales Channels, Direct Sales, and Distribution
 Figure 54. Methodology
 Figure 55. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novartis
Bayer Pharmaceuticals
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Apotex Inc.
Mylan Pharms Inc.
Bulat Pharmaceutical
MSN Laboratories
Vannsh Life Sciences
Beacon Pharmaceuticals
Drug International
Deciphera Pharmaceuticals
CSPC Pharmaceuticals
Hansoh Pharmaceuticals
Kelun Pharmaceuticals
Zai Lab
CStone Pharmaceuticals
China Biopharmaceuticals

Related Reports

Global Gastrointestinal Stromal Tumor Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Gastrointestinal Stromal Tumor Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 29 Jul 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Gastrointestinal Stromal Tumor Drug market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

Product Tags

Gastrointestinal Stromal Tumor Drug

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>